Altered development and function of the placental regions in preeclampsia and its association with long‐chain polyunsaturated fatty acids

Abstract

The placenta is an essential organ formed during pregnancy that mainly transfers nutrients from the mother to the fetus. Nutrients taken up by the placenta are required for its own growth and development and to optimize fetal growth. Hence, placental function is an important determinant of pregnancy outcome. Among various nutrients, fatty acids, especially long-chain polyunsaturated fatty acids (LCPUFAs), including omega 3 and omega 6 fatty acids, are essential for placental development from the time of implantation. Studies have associated these LCPUFAs with placental development through their roles in regulating oxidative stress, angiogenesis, and inflammation, which may in turn influence their transfer to the fetus. The placenta has a heterogeneous morphology with variable regional vasculature, oxidative stress, and LCPUFA levels in healthy pregnancies depending upon the location within the placenta. However, these regional structural and functional parameters are found to be disturbed in pathological conditions, such as preeclampsia (PE), thereby affecting pregnancy outcome. Hence, the alterations in LCPUFA metabolism and transport in different regions of the PE placenta as compared with normal placenta could potentially be contributing to the pathological features of PE. The regional variations in development and function of the placenta and its possible association with placental LCPUFA metabolism and transport in normal and PE pregnancies are discussed in this review. WIREs Dev Biol 2016, 5:582-597. doi: 10.1002/wdev.238 For further resources related to this article, please visit the WIREs website.

Maternal Eicosapentaenoic Acid Feeding Decreases Placental Lipid Deposition and Improves the Homeostasis of Oxidative Stress Through a Sirtuin‐1 (SIRT1) Independent Manner

“…Some researches found that the oxidation products of PUFA could induce wound inflammation and promoted angiogenesis . Because the placenta is a highly metabolic organ that requires an abundant source of energy for fetal growth, it is reasonable to assume that some of the EPA was oxidized, and that the oxidation products have a major proinflammatory and proangiogenic effect in the placenta . As expected, the data presented here showed that MDA concentrations were significantly increased in placenta and fetuses.…”

Omega-3 Long-Chain Polyunsaturated Fatty Acids and Preeclampsia: Trials Say “No,” but Is It the Final Word?

“…Omega-3 fatty acids and particularly DHA reduce placental oxidative stress and increase the levels of resolvins and protectins that also help to keep oxidation at bay. However, the free radicals peroxidize LCPUFA produce toxic molecules [ 42 ]. This ambivalence may partially explain failure of LCPUFA to prevent preeclampsia in clinical trials.…”

Omega‐3 fatty acids and risk of preeclampsia

“…Omega‐3 fatty acids have several roles to play during early placentation until delivery. In our recent review article, we have elaborated all the possible roles of omega‐3 fatty acids in placental growth and development from the time of implantation . Omega‐3 fatty acids can also regulate placental inflammation and oxidative stress, the key pathological conditions repeatedly reported in the case of PE.…”